Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Addressing the challenges of the clinical application of pharmacogenetic testing.

Ikediobi ON, Shin J, Nussbaum RL, Phillips KA; UCSF Center for Translational and Policy Research on Personalized Medicine., Walsh JM, Ladabaum U, Marshall D.

Clin Pharmacol Ther. 2009 Jul;86(1):28-31. doi: 10.1038/clpt.2009.30. Review.

2.

Pharmacogenetics: from discovery to patient care.

Shin J, Kayser SR, Langaee TY.

Am J Health Syst Pharm. 2009 Apr 1;66(7):625-37. doi: 10.2146/ajhp080170. Review.

PMID:
19299369
3.

Challenges to integrating pharmacogenetic testing into medication therapy management.

Haga SB, Allen LaPointe NM, Moaddeb J.

J Manag Care Spec Pharm. 2015 Apr;21(4):346-52. Review.

4.

The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions.

Marques SC, Ikediobi ON.

Hum Genomics. 2010 Apr;4(4):238-49. Review.

5.

Clinical pharmacogenomics: opportunities and challenges at point of care.

Scott SA.

Clin Pharmacol Ther. 2013 Jan;93(1):33-5. doi: 10.1038/clpt.2012.196. Review. No abstract available.

6.

Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.

Gervasini G, Benítez J, Carrillo JA.

Eur J Clin Pharmacol. 2010 Aug;66(8):755-74. doi: 10.1007/s00228-010-0857-7. Review.

PMID:
20582584
7.

Personalizing medicine with clinical pharmacogenetics.

Scott SA.

Genet Med. 2011 Dec;13(12):987-95. doi: 10.1097/GIM.0b013e318238b38c. Review.

8.

Clinical implementation of pharmacogenetics.

García-González X, Cabaleiro T, Herrero MJ, McLeod H, López-Fernández LA.

Drug Metab Pers Ther. 2016 Mar;31(1):9-16. doi: 10.1515/dmpt-2015-0031. Review.

9.

Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?

Soh TI, Yong WP.

Ann Acad Med Singapore. 2011 Aug;40(8):350-5. Review.

10.

Developing pharmacogenetic evidence throughout clinical development.

Burns DK.

Clin Pharmacol Ther. 2010 Dec;88(6):867-70. doi: 10.1038/clpt.2010.246. Review.

PMID:
20981004
11.

Pharmacogenomics: a new clinical or regulatory paradigm? European experiences of pharmacogenomics in drug regulation and regulatory initiatives.

Prasad K, Breckenridge A.

Drug Discov Today. 2011 Oct;16(19-20):867-72. doi: 10.1016/j.drudis.2011.08.016. Review.

PMID:
21920454
12.

Pharmacogenetic testing in psychiatry: a review of features and clinical realities.

de Leon J, Arranz MJ, Ruaño G.

Clin Lab Med. 2008 Dec;28(4):599-617. doi: 10.1016/j.cll.2008.05.003. Review.

PMID:
19059065
13.

Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2014 Nov;52(11):13-6. doi: 10.3928/02793695-20141021-09. Review.

PMID:
25375387
14.

The emerging era of pharmacogenomics: current successes, future potential, and challenges.

Lee JW, Aminkeng F, Bhavsar AP, Shaw K, Carleton BC, Hayden MR, Ross CJ.

Clin Genet. 2014 Jul;86(1):21-8. doi: 10.1111/cge.12392. Review.

15.

Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.

Evans BJ.

Clin Pharmacol Ther. 2010 Dec;88(6):749-51. doi: 10.1038/clpt.2010.237. Review.

PMID:
21081943
16.

Progress towards the integration of pharmacogenomics in practice.

Mooney SD.

Hum Genet. 2015 May;134(5):459-65. doi: 10.1007/s00439-014-1484-7. Review.

17.

Use of plasmid-derived external quality control samples in pharmacogenetic testing.

van der Straaten T, Swen J, Baak-Pablo R, Guchelaar HJ.

Pharmacogenomics. 2008 Sep;9(9):1261-6. doi: 10.2217/14622416.9.9.1261. Review.

18.

The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.

O'Donnell PH, Bush A, Spitz J, Danahey K, Saner D, Das S, Cox NJ, Ratain MJ.

Clin Pharmacol Ther. 2012 Oct;92(4):446-9. doi: 10.1038/clpt.2012.117. Review.

19.

[The value of pharmacogenetic tests in antidepressive medication therapy].

Kirchheiner J, Sasse J, Roots I, Brockmöller J, Bauer M.

Nervenarzt. 2005 Nov;76(11):1340-54. Review. German.

PMID:
15864514
20.

Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.

Yan L, Beckman R.

Biotechniques. 2005 Oct;39(10 Suppl):S565-8. doi: 10.2144/000112043. Review.

Supplemental Content

Support Center